APAC Clinical Diagnostics Sector Reviewed in New In-demand Infiniti Research Report Available at MarketPublishers.com
23 Oct 2015 • by Natalie Aster
LONDON – A timely and accurate diagnosis of life-threatening conditions like cardiovascular diseases, cancer, and influenza is expected to increase the sales of clinical diagnostics products. A rapid hike in the number of people living with diabetes in developing nations such as in India is set to boost diagnostics sales as there are 50 million diabetic patients. Diabetes can raise the risk of active tuberculosis, and this infection can negatively affect the blood sugar concentration. To handle these types of clinical events, rapid molecular diagnosis of tuberculosis is set.
The APAC region’s clinical diagnostics market is forecast to post a CAGR of just under 13% through to 2019. The drivers of the growth of the sector comprise POC home diagnostics, market expansion, government investments, and local manufacturing of devices in China, among others. The market has also seen the rising trends towards privatisation and healthcare coverage, personalised medicines, next-gen technology and DNA microarrays, amid others. However, the market growth could be hindered by the lack of infrastructure and well-trained professionals, issues with intellectual property rights, availability of counterfeit in-vitro diagnostics products, pricing policies and unfavourable reimbursement policies in China, etc.
Beckman Coulter Diagnostics, Abbott, Biomerieux, Qiagen and Roche are the leading companies active in the clinical diagnostics market.
New in-demand study “Clinical Diagnostics Market in APAC - Market Analysis 2015-2019” created by Infiniti Research provides a detailed analysis of the clinical diagnostics marketplace in the APAC region. To estimate the market size, the study provides an examination of the revenue obtained through the sales of instruments, diagnostic kits, and reagents, such as POC, clinical microbiology, tissue diagnostic, molecular diagnostic, immunodiagnostics and hematology. The report covers the current performance of the clinical diagnostic market in the region and also sheds light on its growth prospects in the next few years. The report canvasses looks at the impact of regulatory services on clinical diagnostic devices, discusses major market segments, reviews the clinical pipeline, outlines key market drivers and challenges, etc. The report presents a discussion of the dominant vendors operating in the market.
Clinical Diagnostics Market in APAC - Market Analysis 2015-2019
Published: October, 2015
Price: US$ 2,500.00
More new reports by the publisher are available at Infiniti Research page.